Carlson S S, Wight T N
Department of Physiology and Biophysics, University of Washington, Seattle 98195.
J Cell Biol. 1987 Dec;105(6 Pt 2):3075-86. doi: 10.1083/jcb.105.6.3075.
The plasma membranes of the nerve terminal and the postsynaptic cell of electric organ are separated by a basal lamina. We have purified, biochemically characterized, and visualized in the electron microscope a macromolecule which appears to anchor the nerve terminal to this basal lamina. This molecule, terminal anchorage protein 1 (TAP-1) is associated with the nerve terminal membrane of electric organ, has the properties of an integral membrane protein, and is tightly bound to the extracellular matrix (Carlson, S.S., P. Caroni, and R.B. Kelly. 1986. J. Cell Biol. 103:509-520). TAP-1 can be solubilized from an electric organ extracellular matrix preparation with guanidine-HCl/3-[(3-cholamidopropyl)-dimethylammnio]-1-propane sulfonate and purified by a combination of permeation chromatography on Sephacryl S-1000, sedimentation velocity, and ion exchange chromatography on DEAE Sephacel. The total purification from electric organ is 91-fold and results in at least 86% purity. Digestion of the molecule with chondroitin ABC or AC lyase produces a large but similar shift in the molecular weight of the molecule on SDS-PAGE. The presence of chondroitin-4- or 6-sulfate is confirmed by identification of the isolated glycosaminoglycans with cellulose acetate electrophoresis. Gel filtration of the isolated chains indicates an average molecular weight of 42,000. Digestion of TAP-1 with other glycosaminoglycan lyases such as heparitinase indicates that only chondroitin sulfate is present. These results demonstrate that TAP-1 is a proteoglycan. Visualization of TAP-1 in the electron microscope reveals a "bottlebrush" structure expected for a proteoglycan. The molecule has an average total length of 345 +/- 17 nm with 20 +/- 2 side projections of 113 +/- 5 nm in length. These side projections are presumably the glycosaminoglycan side chains. From this structure, we predict that the TAP-1 glycosaminoglycan side chains should have a molecular weight of approximately 50,000, which is in close agreement with the biochemical studies. Both biochemical and morphologic data indicate that TAP-1 has a relative molecular weight of approximately 1.2 X 10(6). The large size of TAP-1 suggests that this molecule could span the synaptic cleft and make a significant contribution to the structure of the nerve terminal basal lamina of electric organ.
神经末梢的质膜与电器官的突触后细胞被基膜分隔开。我们已经对一种大分子进行了纯化、生化特性鉴定,并在电子显微镜下进行了观察,该大分子似乎将神经末梢锚定在这个基膜上。这种分子,即末梢锚定蛋白1(TAP-1),与电器官的神经末梢膜相关,具有整合膜蛋白的特性,并紧密结合于细胞外基质(卡尔森,S.S.,P.卡罗尼,和R.B.凯利。1986。《细胞生物学杂志》103:509 - 520)。TAP-1可以用盐酸胍/3-[(3-胆酰胺丙基)-二甲基铵]-1-丙烷磺酸盐从电器官细胞外基质制剂中溶解出来,并通过在Sephacryl S-1000上的渗透色谱、沉降速度以及在DEAE Sephacel上的离子交换色谱相结合的方法进行纯化。从电器官中总的纯化倍数为91倍,纯度至少为86%。用软骨素ABC或AC裂解酶消化该分子会在SDS-PAGE上使分子的分子量产生大但相似的变化。通过用醋酸纤维素电泳鉴定分离出的糖胺聚糖,证实了硫酸软骨素-4-或6-硫酸盐的存在。对分离出的链进行凝胶过滤表明平均分子量为42,000。用其他糖胺聚糖裂解酶如肝素酶消化TAP-1表明仅存在硫酸软骨素。这些结果证明TAP-1是一种蛋白聚糖。在电子显微镜下观察TAP-1揭示了一种蛋白聚糖预期的“刷状”结构。该分子的平均总长度为345±17nm,有20±2个长度为113±5nm的侧突。这些侧突大概是糖胺聚糖侧链。根据这个结构,我们预测TAP-1糖胺聚糖侧链的分子量应该约为50,000,这与生化研究结果密切相符。生化和形态学数据均表明TAP-1的相对分子量约为1.2×10⁶。TAP-1的大尺寸表明该分子可以跨越突触间隙,并对电器官神经末梢基膜的结构做出重大贡献。